Drug-loaded micelles showed stronger cellular growth inhibition than free drugs against 4T1 (CD44+) breast cancer cells, while no significant differences in growth inhibition were observed between drug-loaded micelles and free drugs in control cells characterized by the lack of expression of CD44 receptors. Here, CD44 is linked to breast carcinoma.